1. Home
  2. PAYP vs RGEN Comparison

PAYP vs RGEN Comparison

Compare PAYP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PayPay Corporation American Depository Shares

PAYP

PayPay Corporation American Depository Shares

N/A

Current Price

$14.78

Market Cap

9.8B

Sector

Real Estate

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$173.57

Market Cap

11.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAYP
RGEN
Founded
2018
1981
Country
Japan
United States
Employees
N/A
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
11.0B
IPO Year
2025
1995

Fundamental Metrics

Financial Performance
Metric
PAYP
RGEN
Price
$14.78
$173.57
Analyst Decision
Buy
Buy
Analyst Count
13
21
Target Price
$24.06
★ $203.45
AVG Volume (30 Days)
508.2K
★ 1.3M
Earning Date
11-03-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 286.96
EPS
★ N/A
N/A
Revenue
N/A
★ $141,236,000.00
Revenue This Year
$24.65
$14.98
Revenue Next Year
$18.06
$26.05
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 35.10
52 Week Low
$12.07
$100.99
52 Week High
$24.89
$198.87

Technical Indicators

Market Signals
Indicator
PAYP
RGEN
Relative Strength Index (RSI) 46.84 46.24
Support Level $14.37 $161.15
Resistance Level $16.41 $188.59
Average True Range (ATR) 0.65 8.82
MACD 0.06 -1.00
Stochastic Oscillator 35.48 28.96

Price Performance

Historical Comparison
PAYP
RGEN

About PAYP PayPay Corporation American Depository Shares

PayPay is a financial technology company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: